Illumina (NASDAQ: ILMN) today announced a sequencing agreement with the San Diego Zoo Wildlife Alliance (SDZWA)’s Frozen Zoo®. The 50-year-old biobank is the world’s most comprehensive and diverse ...

Illumina, which specializes in DNA sequencing, will work on samples representing 1,300 species in the San Diego Zoo Wildlife Alliance's Frozen Zoo.

Opportunities in the Next Generation Cancer Diagnostics Market include leveraging advancements in genomic and proteomic ...

Centralized migration accelerates adaptation and drives parallel evolution, emphasizing the key influence of spatial organization on evolutionary dynamics across systems from pathogen transmission to ...

The market for microbiome sample preparation technology presents opportunities driven by demand for personalized medicine, ...

With the MiSeq™ i100 Series, Illumina continues to set the highest standards. Advancements in system design, sequencing chemistry, and data analysis deliver the simplest, fastest benchtop sequencing ...

TEL AVIV, Israel & LEHI, Utah & HOUSTON & FREMONT, Calif.--(BUSINESS WIRE)--MyHeritage, the leading global platform for family history and DNA testing, announced today a landmark move to Whole Genome ...

BOSTON, Nov. 12, 2025 /PRNewswire/ -- Volta Labs, a leader in NGS automation, today announced a major expansion of its Callisto™ Sample Preparation Platform. Callisto now delivers fully automated DNA ...

Study shows that rare variants captured by Illumina WGS with DRAGEN™ variant calling explain most of the "missing heritability" in complex human diseases and traits, including those related to blood ...

Illumina exhibits better profitability ratios than many of its peers, which indicates that the company could continue to invest in its operations. In Q3 2025, ILMN raised its EPS to $4.65-$4.75, ...

Boston Children's Hospital, along with Broad Clinical Labs and Roche Sequencing Solutions, has demonstrated that rapid genomic sequencing and interpretation are achievable in a matter of hours. This ...